149 related articles for article (PubMed ID: 22777770)
1. Improved burns therapy: liposomes-in-hydrogel delivery system for mupirocin.
Hurler J; Berg OA; Skar M; Conradi AH; Johnsen PJ; Skalko-Basnet N
J Pharm Sci; 2012 Oct; 101(10):3906-15. PubMed ID: 22777770
[TBL] [Abstract][Full Text] [Related]
2. Liposomes-in-hydrogel delivery system with mupirocin: in vitro antibiofilm studies and in vivo evaluation in mice burn model.
Hurler J; Sørensen KK; Fallarero A; Vuorela P; Škalko-Basnet N
Biomed Res Int; 2013; 2013():498485. PubMed ID: 24369533
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen.
Abioye AO; Issah S; Kola-Mustapha AT
Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660
[TBL] [Abstract][Full Text] [Related]
4. Liposome-loaded chitosan physical hydrogel: toward a promising delayed-release biosystem.
Billard A; Pourchet L; Malaise S; Alcouffe P; Montembault A; Ladavière C
Carbohydr Polym; 2015 Jan; 115():651-7. PubMed ID: 25439944
[TBL] [Abstract][Full Text] [Related]
5. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
[TBL] [Abstract][Full Text] [Related]
6. Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration.
Najm MB; Rawas-Qalaji M; Assar NH; Yahia R; Hosary RE; Ahmed IS
Eur J Pharm Sci; 2022 Sep; 176():106251. PubMed ID: 35788029
[TBL] [Abstract][Full Text] [Related]
7. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice.
Jaspers ME; Breederveld RS; Tuinebreijer WE; Diederen BM
Burns; 2014 Dec; 40(8):1570-4. PubMed ID: 24685351
[TBL] [Abstract][Full Text] [Related]
9. Development of Emulgel Delivery of Mupirocin for Treatment of Skin Infection.
Jagdale SC; Kothekar PV
Recent Pat Antiinfect Drug Discov; 2020; 15(2):137-156. PubMed ID: 32814540
[TBL] [Abstract][Full Text] [Related]
10. Sol-gel processed mupirocin silica microspheres loaded collagen scaffold: a synergistic bio-composite for wound healing.
Perumal S; Ramadass Sk; Madhan B
Eur J Pharm Sci; 2014 Feb; 52():26-33. PubMed ID: 24514452
[TBL] [Abstract][Full Text] [Related]
11. The Antimicrobial Properties of Chitosan Can be Tailored by Formulation.
Jøraholmen MW; Bhargava A; Julin K; Johannessen M; Škalko-Basnet N
Mar Drugs; 2020 Jan; 18(2):. PubMed ID: 32023890
[TBL] [Abstract][Full Text] [Related]
12. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
Cui F; Li G; Huang J; Zhang J; Lu M; Lu W; Huan J; Huang Q
Drug Deliv; 2011 Apr; 18(3):173-80. PubMed ID: 20726806
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of topical hydrogel membranes; a novel approach to treat skin disorders.
Ahmad S; Minhas MU; Ahmad M; Sohail M; Khalid Q; Abdullah O
J Mater Sci Mater Med; 2018 Dec; 29(12):191. PubMed ID: 30539389
[TBL] [Abstract][Full Text] [Related]
14. The effect of lipid composition and liposome size on the release properties of liposomes-in-hydrogel.
Hurler J; Žakelj S; Mravljak J; Pajk S; Kristl A; Schubert R; Škalko-Basnet N
Int J Pharm; 2013 Nov; 456(1):49-57. PubMed ID: 23994014
[TBL] [Abstract][Full Text] [Related]
15. Elastic liposomes-in-vehicle formulations destined for skin therapy: the synergy between type of liposomes and vehicle.
Palac Z; Hurler J; Škalko-Basnet N; Filipović-Grčić J; Vanić Ž
Drug Dev Ind Pharm; 2015; 41(8):1247-53. PubMed ID: 25019501
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
Rode H; de Wet PM; Millar AJ; Cywes S
J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of a new processing approach for manufacturing topical liposomes-in-hydrogel drug formulations by dual asymmetric centrifugation.
Ingebrigtsen SG; Škalko-Basnet N; Holsæter AM
Drug Dev Ind Pharm; 2016 Sep; 42(9):1375-83. PubMed ID: 26710826
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
[TBL] [Abstract][Full Text] [Related]
19. Povidone-iodine liposomes--an overview.
Reimer K; Fleischer W; Brögmann B; Schreier H; Burkhard P; Lanzendörfer A; Gümbel H; Hoekstra H; Behrens-Baumann W
Dermatology; 1997; 195 Suppl 2():93-9. PubMed ID: 9403264
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel Loaded Nanoliposomes in Thermosensitive Hydrogel: A Dual Approach for Sustained and Localized Delivery.
Mahajan M; Utreja P; Jain SK
Anticancer Agents Med Chem; 2016; 16(3):365-76. PubMed ID: 26255673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
